
Soratib 200mg Tablet
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Sorafenib (200mg)
Overview Soratib 200mg Tablet
Tyrosine kinase inhibitor Sorafenib 200mg tablets are indicated for liver, kidney, and thyroid cancers. Administer on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescription; incorrect usage or overdose can cause severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include fatigue, nausea, anorexia, alopecia, and diarrhea. Hypertension is possible, necessitating regular blood pressure monitoring. Report severe skin reactions (rash), or hand/foot pain, swelling, or redness immediately. Prior to commencing treatment, disclose any pre-existing heart, liver, kidney disease, or hypertension. Inform your healthcare provider of all concurrent medications due to potential interactions. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.
Uses of Soratib 200mg Tablet
Malignancies affecting the liver, kidneys, and thyroid gland.
Major Benefits of Soratib 200mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 200mg Soratib tablet whole; do not crush, chew, or divide it. Administer this medication on an empty stomach.
Common Side effects of Soratib 200mg Tablet:
- Fatigue
- Nausea
- Loss of appetite
- Diarrhea
- Abdominal pain
- Hair loss
- Weight loss
- Rash
- Painful blisters on hands and feet
How to use Soratib 200mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the 200mg Soratib tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Soratib 200mg Tablet works:
Oncasin 200mg tablets are a cancer treatment. Their mechanism involves inhibiting the activity of a faulty protein that drives cancer cell proliferation, thus curbing or slowing cancerous growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Soratib 200mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Soratib 200mg tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Lactation and Soratib 200mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Driving ability is typically unaffected by Soratib 200mg Tablets.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Soratib 200mg tablets are considered safe, requiring no dosage modification. Routine blood work monitoring during treatment is advisable.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Soratib 200mg tablets, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Soratib 200mg Tablet :
Omit any missed Soratib 200mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Soratib 200mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Diaryl Ether Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
